Albert David Limited (BOM:524075)
684.05
-7.95 (-1.15%)
At close: Jul 27, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 3.9 billion as of July 28, 2026. Its market cap has decreased by -22.94% in one year.
Market Cap
3.90B
Enterprise Value
1.62B
Revenue
3.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
684.05
ChartMarket Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 3.90B, an increase of 4,751.42%. That is a compound annual growth rate of 16.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 3.90B | -7.56% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIM Laboratories | 6.43B |
| Kilitch Drugs (India) | 6.20B |
| Amanta Healthcare | 5.60B |
| Jenburkt Pharmaceuticals | 4.76B |
| BDH Industries | 3.33B |
| Medico Remedies | 3.17B |
| Trident Lifeline | 3.13B |
| Medicamen Biotech | 3.08B |